#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Diabetes insipidus Pelizaeus-Merzbacher disease Anti-myelin-associated glycoprotein associated polyneuropathy Pemphigoid Thrombocytopenia Biotinidase deficiency Angiosarcoma non-metastatic Neuronal ceroid lipofuscinosis Cholestatic pruritus Soft tissue necrosis Cryoglobulinaemia Dent's disease Fallopian tube cancer Pancreatic carcinoma HER2 gene amplification More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Basic Information Wiskott-Aldrich syndrome – Trials in Disease Lymphangiosarcoma – Diagnostics Cystic fibrosis – Basic Information Primary immunodeficiency syndrome – Life with Disease Haemophilia B with anti factor IX – Life with Disease Rhabdomyosarcoma recurrent Atypical haemolytic uraemic syndrome Sarcoma – Life with Disease MELAS syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lisocabtagene Maraleucel HUPERZINE A Dl-Alpha-Tocopherol Mcla-129 Upadacitinib SONLICROMANOL HYDROCHLORIDE Specific Nucleic Acid Sna-Veru Cefotaxime Thiamine Nitrate Caffeine Citrate Aflibercept Difelikefalin ALE.P03 Raludotatug Deruxtecan TORASEMIDE Loperamide Hydrochloride Ampreloxetine Norfloxacin Motixafortide Ocrelizumab More therapies…

    Learn about Your Condition

    Vulvovaginal pain Anal abscess Cervix carcinoma stage IV Pterygium Epstein-Barr virus infection Death neonatal Dry mouth Bipolar I disorder Hypoalbuminaemia Acute on chronic liver failure Amnestic disorder Cholestatic pruritus Alveolar rhabdomyosarcoma Thrombolysis Myocarditis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Duvakitug
    Austria Belgium Bulgaria Czechia France Germany +6

  • Study on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury

    Not recruiting

    2 1
    Investigated Diseases:
    • Sepsis
    • Acute kidney injury
    Investigated Drugs:
    • Tin816
    Austria Belgium Czechia France Germany Hungary +2

  • Study on Safety and Efficacy of Bepirovirsen and Drug Combination for Chronic Hepatitis B in Patients on Nucleos(t)ide Analogue Therapy

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic hepatitis B
    • Hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    • Gskvx000000008866
    • Gskvx000000008885
    Belgium Bulgaria France Germany Italy Poland +2

  • Study of ONCOFID-P-B for Patients with Bladder Carcinoma in Situ Unresponsive to BCG Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Bladder cancer stage 0 with cancer in situ
    Investigated Drugs:
    • Paclitaxel Obaluronate
    France Italy Poland Spain

  • Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lebrikizumab
    Austria Denmark France Italy Spain Sweden

  • Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Mitomycin
    • Gemcitabine Hydrochloride
    Belgium France Germany Italy Poland Romania +1

  • Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
    Austria Belgium Bulgaria Czechia Denmark France +6

  • Study on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    2 1
    Investigated Diseases:
    • Heart failure with reduced ejection fraction
    Investigated Drugs:
    • Tovinontrine
    Belgium Bulgaria Czechia Germany Hungary Italy +6

  • Study on the Effects of Mepolizumab for Achieving Clinical Remission in Patients with Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Mepolizumab
    Belgium France Germany Italy Poland Spain

  • Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Placebo
    • Carboplatin
    • Cisplatin
    Austria Bulgaria France Germany Italy Poland +1
Previous Page
1 … 51 52 53 54 55 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!